583 related articles for article (PubMed ID: 14766303)
1. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization.
Zhou Z; Schnake P; Xiao L; Lal AA
Protein Expr Purif; 2004 Mar; 34(1):87-94. PubMed ID: 14766303
[TBL] [Abstract][Full Text] [Related]
2. Development of pilot scale production process and characterization of a recombinant multiepitope malarial vaccine candidate FALVAC-1A expressed in Escherichia coli.
Ravi G; Ella K; Lakshmi Narasu M
Protein Expr Purif; 2008 Sep; 61(1):57-64. PubMed ID: 18619853
[TBL] [Abstract][Full Text] [Related]
3. A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli.
Li M; Bi H; Dong W; Xu W; Li Q; Li Y
Chin Med J (Engl); 1999 Aug; 112(8):691-7. PubMed ID: 11601273
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of Falcipain-2 in Escherichia coli by codon optimization and auto-induction.
Sarduy ES; Muñoz AC; Trejo SA; de los A Chavéz Planes M
Protein Expr Purif; 2012 May; 83(1):59-69. PubMed ID: 22450163
[TBL] [Abstract][Full Text] [Related]
5. Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimization.
Yazdani SS; Shakri AR; Pattnaik P; Rizvi MM; Chitnis CE
Biotechnol Lett; 2006 Jul; 28(14):1109-14. PubMed ID: 16794771
[TBL] [Abstract][Full Text] [Related]
6. Optimized expression of Plasmodium falciparum erythrocyte membrane protein 1 domains in Escherichia coli.
Flick K; Ahuja S; Chene A; Bejarano MT; Chen Q
Malar J; 2004 Dec; 3():50. PubMed ID: 15601471
[TBL] [Abstract][Full Text] [Related]
7. Intranasal administration of an Escherichia coli-expressed codon-optimized rotavirus VP6 protein induces protection in mice.
Choi AH; Basu M; McNeal MM; Bean JA; Clements JD; Ward RL
Protein Expr Purif; 2004 Dec; 38(2):205-16. PubMed ID: 15555936
[TBL] [Abstract][Full Text] [Related]
8. Codon optimization can improve expression of human genes in Escherichia coli: A multi-gene study.
Burgess-Brown NA; Sharma S; Sobott F; Loenarz C; Oppermann U; Gileadi O
Protein Expr Purif; 2008 May; 59(1):94-102. PubMed ID: 18289875
[TBL] [Abstract][Full Text] [Related]
9. [Preliminary study of a recombinant polyvalent vaccine of Plasmodium falciparum and its immunological activity].
Li Q; Li Y; Xie Y
Zhonghua Yi Xue Za Zhi; 1995 Jun; 75(6):325-8, 381. PubMed ID: 7553140
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
11. [Chemical synthesis and cloning of Plasmodium falciparum 45 peptide antigen gene].
Qiu MY; Min YJ; Wang QS; Zhong XL; Cheng SR; Wang CC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1992; 10(2):82-5. PubMed ID: 1394913
[TBL] [Abstract][Full Text] [Related]
12. Codon optimization of the gene encoding a domain from human type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli.
Hale RS; Thompson G
Protein Expr Purif; 1998 Mar; 12(2):185-8. PubMed ID: 9518459
[TBL] [Abstract][Full Text] [Related]
13. Overexpression and purification of Pyrococcus abyssi phosphopantetheine adenylyltransferase from an optimized synthetic gene for NMR studies.
Nálezková M; de Groot A; Graf M; Gans P; Blanchard L
Protein Expr Purif; 2005 Feb; 39(2):296-306. PubMed ID: 15642482
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
[TBL] [Abstract][Full Text] [Related]
15. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
16. [Cloning and sequencing of the gene coding the sexual stage antigen Pfs48/45 of Plasmodium falciparum].
Luo S; Yu X; Liu Y; Fang J; Xu J; Li X
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1998; 16(6):406-10. PubMed ID: 12078283
[TBL] [Abstract][Full Text] [Related]
17. Solid-phase gene assembly of constructs derived from the Plasmodium falciparum malaria blood-stage antigen Ag332.
Ståhl S; Hansson M; Ahlborg N; Nguyen TN; Liljeqvist S; Lundeberg J; Uhlén M
Biotechniques; 1993 Mar; 14(3):424-34. PubMed ID: 8457350
[TBL] [Abstract][Full Text] [Related]
18. Vaccine candidate MSP-1 from Plasmodium falciparum: a redesigned 4917 bp polynucleotide enables synthesis and isolation of full-length protein from Escherichia coli and mammalian cells.
Pan W; Ravot E; Tolle R; Frank R; Mosbach R; Türbachova I; Bujard H
Nucleic Acids Res; 1999 Feb; 27(4):1094-103. PubMed ID: 9927744
[TBL] [Abstract][Full Text] [Related]
19. [Enhanced prokaryotic expression of a recombinant Lagurus lagurus zona pellucida subunit 3 with codon optimization].
Li YJ; Zhang FC; Zhang Y; Wang YB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):700-3. PubMed ID: 16256030
[TBL] [Abstract][Full Text] [Related]
20. Hyperexpression of rat spermatidal protein TP2 in Escherichia coli by codon optimization and engineering the vector-encoded 5' UTR.
Meetei AR; Rao MR
Protein Expr Purif; 1998 Jul; 13(2):184-90. PubMed ID: 9675061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
